Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Comparison of Statistical Approaches for Dealing With Immortal Time Bias in Drug Effectiveness Studies.
Cortical network dysfunction caused by a subtle defect of myelination.
Optic Neuritis in a Patient with Bickerstaff's Brainstem Encephalitis.
The Relationship between Gray Matter Quantitative MRI and Disability in Secondary Progressive Multiple Sclerosis.
STARs in the CNS.
Impact of the Great East Japan Earthquake in 2011 on MS and NMOSD: a study in Sendai, Japan.
Multiple sclerosis: Pregnancy and women's health issues.
Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis.
Brain Metabolite Changes in Patients with Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: A Two-Year Follow-Up Study.
Corrigendum to "An investigation into the association between HLA-G 14bp insertion/deletion polymorphism and multiple sclerosis susceptibility" [Journal of Neuroimmunology 290 (2016) 115-118].
Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up.
Analysis of Fundus Photography and Fluorescein Angiography in Nonarteritic Anterior Ischemic Optic Neuropathy and Optic Neuritis.
Combining HLA-DRB1-DQB1 and Mycobacterium Avium Subspecies Paratubercolosis (MAP) antibodies in Sardinian multiple sclerosis patients: associated or independent risk factors?
Treatment for Krabbe's disease: Finding the combination.
Efficacity of exercise training on multiple sclerosis patients with cognitive impairments.
Fumarate modulates the immune/inflammatory response and rescues nerve cells and neurological function after stroke in rats.
Medical cannabis - the Canadian perspective.
Histological Basis of Laminar MRI Patterns in High Resolution Images of Fixed Human Auditory Cortex.
Lymphocryptovirus Infection of Nonhuman Primate B Cells Converts Destructive into Productive Processing of the Pathogenic CD8 T Cell Epitope in Myelin Oligodendrocyte Glycoprotein.
A lesion topography-based approach to predict the outcomes of patients with multiple sclerosis treated with Interferon Beta.
Dimethyl fumarate blocks pro-inflammatory cytokine production via inhibition of TLR induced M1 and K63 ubiquitin chain formation.
Role of Therapeutic Plasma Exchange in Treatment of Tumefactive Multiple Sclerosis-Associated Low CD4 and CD8 Levels.
FOXP3(+) Treg Cells and Gender Bias in Autoimmune Diseases.
Type 1 diabetes and susceptibility to multiple sclerosis: What is the truth?
The Effectiveness of Group Cognitive Behavioral Therapy in Treating Obsessive-Compulsive Disorder in Women with Multiple Sclerosis (MS): A randomized double-blind controlled trial.
Pages
« first
‹ previous
…
765
766
767
768
769
770
771
772
773
…
next ›
last »